Navigation Links
ASAM Approves Prescription Drug Policy
Date:1/26/2012

CHEVY CHASE, Md., Jan. 26, 2012 /PRNewswire-USNewswire/ -- "Prescription drug diversion and the health consequences of prescription drug misuse and abuse should be of primary concern to all physicians," states American Society of Addiction Medicine (ASAM) Acting President, Stuart Gitlow, MD.  "Tens of thousands of Americans are overdosing on prescription pain medication and many of these prescriptions are coming from doctors' offices." 

Chronic pain and addiction are issues faced by patients from all walks of life and in all types of treatment settings.  And, yet, very few physicians are sufficiently educated about the potential psychiatric and addiction consequences of prescribing scheduled medications like opioid analgesics and sedative hypnotics (two of the most commonly misused classes of prescription medication).  The Centers for Disease Control and Prevention reports that the sale of prescription pain drugs has increased by 300% since 1999 and the most recent National Survey on Drug Use and Health (Substance Abuse and Mental Health Administration) reports that nearly 1 in 6 non-medical users of prescription pain killers got the drug through a prescription from a doctor.  Currently, there are no requirements that prescribers prove they are competent to prescribe these potentially lethal drugs. 

"Prescription drug use and overdose death are becoming a public health crisis," says Dr. Gitlow.  "Physicians and patients should understand the risks and benefits of using these powerful drugs and make educated treatment choices."  To that end, ASAM recommends that all health professionals who can prescribe scheduled medications must be included in any educational efforts to improve patient outcomes and public health.  One part of the solution is to mandate prescriber education for all health professionals licensed to prescribe, dispense or administer prescription drugs.  A public health resp
'/>"/>

SOURCE American Society of Addiction Medicine
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that ... to the announced tender offer for all of the outstanding shares ... of the waiver, the transaction is no longer conditional on OFT ... 24, 2014 following the currently scheduled expiration time, subject to the ...
(Date:1/15/2014)... 15, 2014 BreedIT Corp (OTC: BRDT), ... distributor of highly sophisticated agro-breeding solutions for plant breeders ... the Company,s board of directors appointed chemistry and pharmaceutical ... new member of the board. From 1975 ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... LAKE CITY, Jan. 28, 2011 TechniScan (OTC Bulletin ... engaged in the development and commercialization of an automated ... Robinson, Chief Executive Officer, will present at RetailInvestorConferences.com. DATE: ... ESTLINK: , www.retailinvestorconferences.com This will be a live, ...
... BioSciences, Inc. (NasdaqCM: DARA), a biopharmaceutical development company ... through proof of concept in humans for subsequent ... today that Richard Franco, CEO, will present at ... 5:00 PM ESTLINK: , www.retailinvestorconferences.com This will ...
Cached Medicine Technology:TechniScan to Present Live, Online at RetailInvestorConferences.com on February 3rd 2DARA BioSciences to Present Live at RetailInvestorConferences.com on February 3 2DARA BioSciences to Present Live at RetailInvestorConferences.com on February 3 3
(Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
(Date:4/17/2014)... NEW YORK, NY (April 16, 2014) The cause ... but a new study proposes that neurons may be ... own immune system, similar to the way autoimmune diseases ... attack the body,s cells. The study was published April ... is a new, and likely controversial, idea in Parkinson,s ...
(Date:4/17/2014)... EcoHealth Alliance, a nonprofit organization that focuses on conservation ... today examining the current state of knowledge of the ... improved global surveillance strategies to combat the emergence of ... in West Africa that has claimed the lives of ... According to the World Health Organization (WHO), the ...
(Date:4/17/2014)... YORK (17 April 2014) Population Council scientists and their ... safe, stable, and can prevent the transmission of multiple ... rectum in animals: HIV, herpes simplex virus 2 (HSV-2), ... the first data that the gel is effective against ... efficacy in the vagina against all three viruses of ...
(Date:4/17/2014)... is less than 40 years away from a food ... governments, according to a top scientist at the U.S. ... human history, food production will be limited on a ... energy," said Dr. Fred Davies, senior science advisor for ... become as politically destabilizing by 2050 as energy issues ...
Breaking Medicine News(10 mins):Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:Food shortages could be most critical world issue by mid-century 2
... government of India.,Clearly positing development against environment, it has asked ... that sits over environmental issues. ,Seeking the vacation ... (FAC), constituted under the Forest Conservation Act, the federal government ... on the ground that it has outlived its utility and ...
... Sir Paul McCartney has offered 20 million pounds to his ... is adamantly demanding 50 million pounds, if reports are ... the couple settled their matter in the range of somewhere ... of estimated 825 million pounds. ,However, their stubbornness ...
... on the Chinese Government to introduce strict regulations to ... summer and winter holiday periods. ,Shang Xiyun ... hearing her eight-year-old daughter declare that she would never ... watching a TV ad for underwear featuring a half-naked ...
... have developed a mathematical model that identifies genes that battle ... ,Researchers conducted a joint study led Dr. Milton Taylor, ... of Evolution of the University of Haifa. ,The ... have had a blood transfusion or who share needles, attacks ...
... found that blood transfusion from donors with undiagnosed cancers ... malignant disease than individuals who receive blood from ... carry out a rigorous battery of tests before the ... diseases are passed between the donor and recipient. Although ...
... the planet, sending automakers back to the drawing board to develop ... ,"There is no doubt that 10 years down ... the planet is going to be higher," said Ghosn, who heads ... ,"The average consumer on earth is going to be much ...
Cached Medicine News:Health News:Indian Government Asks the Supreme Court to Keep Off Environmental Issues 2Health News:Indian Government Asks the Supreme Court to Keep Off Environmental Issues 3Health News:Indian Government Asks the Supreme Court to Keep Off Environmental Issues 4Health News:Blood Transfusions Does Not Increase the Risk of Cancer Transmission 2Health News:Motorists Getting Greyer, Greener, Thriftier: Nissan's Ghosn 2
Proven and Efficient Stand-Alone Device. Offers a choice between alternate breath and every breath delivery. This model provides alternate breath delivery....
... An All-In-One Conserver., ,Offers an average 5:1 ... ,Allows the use of a standard cannula. ... and lightweight cylinders offers ambulatory oxygen patients a ... backed by a 2-year warranty. ...
... ,Offers an average 5:1 increase in usage ... use of a standard cannula. , ,The ... offers ambulatory oxygen patients a superior alternative to ... 2-year warranty. , ...
... Conserver., ,Offers an average 5:1 increase in ... the use of a standard cannula. , ... cylinders offers ambulatory oxygen patients a superior alternative ... a 2-year warranty. , ...
Medicine Products: